Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles, Rx Only, Distributed by Perrigo Minn...
FDA Drug Recall #D-0098-2018 — Class II — November 9, 2017
Recall Summary
| Recall Number | D-0098-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 9, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Mayne Pharma Inc |
| Location | Greenville, NC |
| Product Type | Drugs |
| Quantity | 11,364 bottles |
Product Description
Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles, Rx Only, Distributed by Perrigo Minneapolis, MN 55427, NDC 0574-0222-01
Reason for Recall
Failed Dissolution Specifications.
Distribution Pattern
Nationwide within USA
Lot / Code Information
Lot: #:16F649, Exp: May 2018
Other Recalls from Mayne Pharma Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1152-2022 | Class II | Clonidine Transdermal System, USP 0.3 mg/day, 4... | Jun 9, 2022 |
| D-0387-2022 | Class II | Lexette (halobetasol propionate) Topical Foam, ... | Jan 14, 2022 |
| D-0998-2020 | Class II | Carbidopa and Levodopa Tablets, USP 25 mg/250mg... | Mar 2, 2020 |
| D-1129-2018 | Class III | Oxycodone and Acetaminophen Tablets, USP, 5 mg*... | Aug 21, 2018 |
| D-0616-2018 | Class III | Fabior (tazarotene) Foam, 0.1%, 100 grams can, ... | Mar 21, 2018 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.